ADX-103

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameADX-103
Drug Alias NameADX-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGTPase Ras inhibitors
TargetsGTPase Ras
Therapy Area/IndicationsRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAldeyra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAldeyra Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRetinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A